Olaparib in the metastatic HER2-negative breast cancer setting by L. G. Zhukova, E. I. Khatkova, I. P. Ganshina, I. V. Kolyadina, E. V. Lubennikova

Get full text

Role of palbociclib in the treatment of hormone receptor-positive HER2-negative metastatic breast cancer. Generalizing results of randomized trials and real clinical practice by L. G. Zhukova, E. I. Khatkova, P. S. Feoklistova, K. S. Grechukhina, S. A. Smolin, E. A. Arutyunyan, E. M. Kolyago

Get full text

The use of regorafenib in patients with disseminated gastrointestinal stromal tumours. A review of the literature. A clinical case by D. A. Filonenko, S. V. Petukhova, E. I. Khatkova, K. A. Vorontsova, E. I. Chichikov, B. M. Medvedeva, L. G. Zhukova

Get full text

Target therapy of luminal HER2-negative advanced breast cancer with PIK3CA mutation: combination of alpelisib plus fulvestrant in real clinical practice by D. A. Filonenko, T. M. Ibragimova, N. I. Polshina, A. V. Belogurova, E. I. Khatkova, E. A. Arutiunian, E. I. Volkova, L. G. Zhukova

Get full text

Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy by Yu. A. Vasyuk, E. Y. Shupenina, E. O. Novosel, D. A. Vyzhigin, A. G. Nosova, L. G. Zhukova, D. A. Filonenko, E. I. Khatkova

Get full text